The following discussion should be read in conjunction with the Condensed Consolidated Financial Statements and the related notes that appear elsewhere in this document.



The information in this Quarterly Report on Form 10-Q contains forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as
amended ("Securities Act"), and Section 21E of the Securities Exchange Act of
1934, as amended ("Exchange Act"), which are subject to the "safe harbor"
created by those sections. These forward-looking statements reflect our
management's beliefs and views with respect to future events and are based on
estimates and assumptions as of the date of this report and are subject to risks
and uncertainties. We may, in some cases, use words such as "anticipate,"
"believe," "could," "continue," "estimate," "expect," "intend," "may,"
"objective," "plan," "potential," "predict," "project," "should," "will,"
"would," or the negative of those terms, and similar expressions that convey
uncertainty of future events or outcomes to identify these forward-looking
statements. Forward-looking statements in this report include, but are not
limited to, statements regarding:

• our plans to focus on clock IC and timing sync solutions in the future

and to aggressively expand our presence in these two markets;

• the impact of the COVID-19 pandemic on our business, revenue and other

operating results, liquidity, and cash flows, and its impact on the

businesses of our suppliers and customers, and our anticipated responses


         thereto;


   •     our ability to address market and customer demands and to timely develop
         new or enhanced solutions to meet those demands;

• anticipated trends, challenges and growth in our business and the markets


         in which we operate, including pricing expectations;


  • our expectations regarding our revenue, gross margin, and expenses;

• expected impact of new legistlation and IRS guidance issued in response


         to the COVID-19 pandemic;


   •     our belief as to the sufficiency of our existing cash and cash

equivalents and funds available for borrowing under our credit facilities


         to meet our cash needs for at least the next 12 months and our future
         capital requirements over the longer term, including the potential impact
         of the COVID-19 pandemic thereon;


  • our expectations regarding dependence on our largest customer;


   •     our customer relationships and our ability to retain and expand our
         customer relationships and to achieve design wins;


  • the success, cost, and timing of new products;


   •     the size and growth potential of the markets for our solutions, and our
         ability to serve and expand our presence in those markets;

• our plans to expand sales and marketing efforts through increased

collaboration with our distributors, resellers, and contracted sales

representatives, and our plans to introduce a self-service web portal as

well as digital marketing campaigns for branding and lead generation;

• our goal to become the leading timing solution provider for advanced and


         challenging applications;




   •     our positioning of being designed into current systems as well as future

products;

• our belief that our advanced packaging designs can fit in the smallest

footprints in the industry;

• our expectations regarding competition in our existing and new markets;




  • regulatory developments in the United States and foreign countries;

• the performance of, and our relationships with, our third-party suppliers

and manufacturers;

• our and our customers' ability to respond successfully to technological


         or industry developments;


  • our ability to attract and retain key management personnel;


  • intellectual property and related litigation;


  • the adequacy and availability of our leased facilities;


   •     the accuracy of our estimates regarding capital requirements,
         expectations regarding renewal of loans, and needs for additional
         financing;




                                       14

--------------------------------------------------------------------------------

• our relationship with, and ownership percentage of, MegaChips Corporation


         ("MegaChips");


   •     our expectations regarding the period during which we qualify as an
         emerging growth company under the JOBS Act; and

• our expectations regarding our ability to obtain, maintain, protect, and

enforce intellectual property protection for our technology.




In addition, any statements contained herein that are not statements of
historical facts may be deemed to be forward-looking statements. Forward­looking
statements are subject to a number of risks and uncertainties that could cause
actual results to differ materially from those expected or referenced in these
forward-looking statements. These risks and uncertainties include, but are not
limited to, those risks discussed in Part II, Item 1A Risk Factors of this
report. Moreover, we operate in a very competitive and rapidly changing
environment. New risks emerge from time to time. It is not possible for our
management to predict all risks, nor can we assess the impact of all factors on
our business or the extent to which any factor, or combination of factors, may
cause actual results to differ materially from those contained in any
forward-looking statements we may make. Given these uncertainties, you should
not place undue reliance on these forward-looking statements. We qualify all of
the forward-looking statements in this report by these cautionary statements.

You should not rely upon forward-looking statements as predictions of future
events. Although we believe that the expectations reflected in the
forward-looking statements are reasonable, we cannot guarantee that the future
results, levels of activity, performance, or events and circumstances reflected
in the forward-looking statements will be achieved or occur. Moreover, neither
we nor any other person assumes responsibility for the accuracy and completeness
of the forward-looking statements. We undertake no obligation to update publicly
any forward looking statements for any reason after the date of this report to
conform these statements to actual results or to changes in our expectations,
except as required by law.

Overview

We are a leading provider of silicon timing solutions. Our timing solutions are
the heartbeat of our customers' electronic systems, solving complex timing
problems and enabling industry-leading products. We provide solutions that are
differentiated by high performance and reliability, programmability, small size,
and low power consumption. Our products have been designed into over 200
applications across our target markets, including enterprise and
telecommunications infrastructure, automotive, industrial, IoT and mobile, and
aerospace and defense.

We commenced commercial shipments of our first oscillator products in 2006.
Substantially all of our revenue to date has been derived from sales of
oscillator systems across our target end markets. We intend to introduce
products into the clock IC market, which we began sampling in 2019, and to focus
on clock IC and timing sync solutions in the future. We seek to aggressively
expand our presence in these two markets.

We sell our products primarily through distributors and resellers, who in turn
sell to our end customers. Based on sell-through information provided by these
distributors, we believe the majority of our end customers are based in the U.S.

We operate a fabless business model, allowing us to focus on the design, sales,
and marketing of our products, quickly scale production, and significantly
reduce our capital expenditures. We leverage our global network of distributors
and resellers to address the broad set of end markets we serve. For our largest
accounts, dedicated sales personnel work with the end customer to ensure that
our solutions fully address the end customer's timing needs. Our smaller
customers work directly with our distributors to select the optimum timing
solution for their needs.

We were acquired by MegaChips in 2014 and were a wholly-owned subsidiary of
MegaChips, a fabless semiconductor company based in Japan and traded on the
Tokyo Stock Exchange, until November 25, 2019. On November 25, 2019, we
completed the initial public offering of shares of our common stock. MegaChips
continues to be our largest stockholder and held approximately 44.9% of our
common stock as of June 30, 2020. On June 16, 2020, we completed a follow-on
public offering, in which we issued and sold 1,525,000 shares of our common
stock and MegaChips sold 2,500,000 of our common stock held by them.

Impact of COVID-19 on our Business



The future impact of the global emergence of the COVID-19 pandemic on our
business is currently unknown. In an effort to protect the health and safety of
our employees, we took proactive actions and adopted social distancing policies
at our locations around the world, including WFH, reducing the number of people
in our sites at any one time, and suspending employee travel. In an effort to
contain the COVID-19 pandemic or slow its spread, governments around the world
have also enacted various measures, including orders to close all businesses not
deemed "essential," isolate residents to their homes or places of residence, and
practice social distancing when engaging in essential activities. In addition,
the United States and other foreign countries in which we operate have imposed
measures such as quarantines and "shelter-in-place" orders that are restricting
business operations and travel and requiring individuals to work from home
("WFH"), which has impacted all aspects of our business, as well as those of the
third-parties we rely upon for our manufacturing, assembly, testing, shipping
and other operations.



                                       15

--------------------------------------------------------------------------------


We anticipate the global health crisis caused by the COVID-19 pandemic will
negatively impact business activity across the globe and our results of
operations. We believe that the COVID-19 pandemic has caused, and could continue
to cause, delay and disruption in the manufacture, shipment, and sales of, and
overall demand for, our products. In addition, we believe the production
capabilities of our suppliers has been, and may continue to be, impacted as a
result of quarantines, closures of production facilities, lack of supplies, or
delays caused by restrictions on travel or WFH orders. For example, on March 16,
2020, the government of Malaysia announced measures to restrict movement in that
country to suppress the number of COVID-19 cases. The restrictions have been
extended currently until August 31, 2020. These restrictions could limit our
suppliers' ability to operate their manufacturing facilities in that country.
Any delay or disruption in the manufacture, shipment and sales of, or overall
demand for, our products in turn may negatively and materially impact our
operating and financial results, including revenue, gross margins, operating
margins, cash flows and other operating results. Further, the resumption of
normal business operations after such disruptions may be delayed and a
resurgence of COVID-19 could result in continued disruption to us, our
suppliers, and/or our customers. To date, the Company has experienced minimal
impact from any supplier disruption. The duration and full magnitude of the
COVID-19 pandemic's impact on credit and financial markets is also unknown,
which creates uncertainty as to the financial condition of our distributors or
customers. In addition, the deterioration in credit markets could limit our
ability to obtain external financing to fund our operations and capital
expenditures. We may also experience losses on our holdings of cash and
investments due to failures of financial institutions and other parties.

We currently have employees, third-party contractors, distributors, and
customers in numerous countries throughout the world that have each been
impacted by the COVID-19 pandemic. The COVID-19 pandemic has restricted and is
expected to continue to restrict travel and use of our facilities and the
facilities of our suppliers, customers, or other vendors in our supply chain,
which could impact our business, interactions and relationships with our
customers, third-party suppliers and contractors, and results of operations. We
cannot predict with certainty what other impacts the COVID-19 pandemic may have
on our business and results of operations.

There remains a high degree of uncertainty in the global business environment
given the impact of the COVID-19 pandemic which creates challenges with
visibility beyond the near term. We will continue to actively monitor the
situation and may take further actions altering our business operations that we
determine are in the best interests of our employees, customers, partners,
suppliers, and stakeholders, or as required by federal, state, or local
authorities. It is not clear what the potential effects any such alterations or
modifications may have on our business, including the effects on our customers,
employees, operations, and prospects, or on our financial results for the
remainder of fiscal 2020 or beyond. For additional discussion, please see Part
II, Item 1A Risk Factors of this report.

Results of Operations

Revenue



We derive revenue primarily from sales of silicon timing products to
distributors and resellers who in turn sell to our end customers. We also sell
products directly to end customers who integrate our products into their
applications. Our sales are made pursuant to standard purchase orders which may
be cancelled, reduced, or rescheduled, with little or no notice. We recognize
product revenue upon shipment when we satisfy our performance obligations as
evidenced by the transfer of control of our products to customers. We measure
revenue based on the amount of consideration we expect to be entitled to in
exchange for products.



                        Three Months Ended June 30,              Change              Six Months Ended June 30,               Change
                         2020                 2019             $         %           2020                2019             $           %
                                                              (in thousands except percentage)
Revenue             $       21,473       $       15,843     $ 5,630       36 %   $      43,215       $      30,660     $ 12,555        41 %




Revenue increased by $5.6 million, or 36%, for three months ended June 30, 2020
compared to the same period in the prior year. The revenue from our customers
largely in Asia increased $5.2 million primarily from higher sales volume of 17%
and an increase in ASP of $0.08 drive by the mix of products. The remaining
increase was primarily related to increased revenue of $0.4 million from our
largest customer from higher sales volume and higher ASP driven by the change in
the mix of the products sold.



Revenue increased by $12.6 million, or 41%, for six months ended June 30, 2020
compared to the same period in the prior year. The revenue from our customers
largely in Asia increased $10.8 million primarily from higher sales volume of
39% and an increase in ASP of $0.03. The remaining increase was primarily
related to increased revenue of $1.7 million from our largest customer from
higher sales volume and higher ASP driven by mix of products sold. The overall
average selling price of our products increased by $0.03 year over year driven
mostly by mix of products.





                                       16

--------------------------------------------------------------------------------


For the three and six months ended June 30, 2020, sales attributable to our
largest end customer accounted for 26% and 30% of our revenue, respectively. For
the three and six months ended June 30, 2020, our top three distributors by
revenue together accounted for approximately 51% and 54% of our revenue,
respectively. Revenue attributable to our largest ten end customers accounted
for 50% and 51% respectively for the three and six months ended June 30, 2020.

Cost of Revenue, Gross Profit, and Gross Margin



Cost of revenue consists of wafers acquired from third-party foundries,
assembly, packaging, and test cost of our products paid to third-party contract
manufacturers, and personnel and other costs associated with our manufacturing
operations. Cost of revenue also includes depreciation of production equipment,
inventory write-downs, amortization of internally developed software, shipping
and handling costs, and allocation of overhead and facility costs. We also
include credits for rebates received from foundries to cost of revenue.



                       Three Months Ended June 30,             Change              Six Months Ended June 30,              Change
                         2020                2019            $         %           2020                2019             $          %
                               (in thousands except percentage)                           (in thousands except percentage)

Cost of Revenue     $       11,490       $      9,469     $ 2,021       21 %   $      23,256       $      16,697     $ 6,559        39 %
Gross Profit                 9,983              6,374       3,609       57 %          19,959              13,963       5,996        43 %
Gross Margin                    46 %               40 %                                   46 %                46 %




Gross profit increased by $3.6 million in the three months ended June 30, 2020
compared to the same period in the prior year. The gross profit for the period
ended June 30, 2019 included a benefit of $0.4 million from the sale of
previously reserved inventory. Gross profit excluding this benefit of $0.4
million increased $4.0 million year over year mainly from higher sales volume
and a slight increase in ASP as other manufacturing costs remained relatively
flat.



Gross profit increased by $6.0 million in the six months ended June 30, 2020
compared to the same period in the prior year. The gross profit for the period
ended June 30, 2019 included a benefit of $1.7 million from the sale of
previously reserved inventory. Gross profit excluding this benefit of $1.7
million increased $7.7 million year over year mainly from higher sales volume
and an increase in ASP as other manufacturing costs remained relatively flat.



Gross margin was higher by 6% in the three months ended June 30, 2020 when
compared to the same period in the prior year. The gross margin for the period
ended June 30, 2019 included a benefit of 2% or $0.4 million from sale of
previously reserved inventory. The gross margin excluding the benefit to the
gross margin from the sale of the previosly reserved inventoy increased by 9%
year over year from higher sales volume and a slight increase in ASP as other
manufacturing costs remained relatively flat.



Gross margin was flat in the six months ended June 30, 2020 when compared to the
same period in the prior year. The gross margin for the period ended June 30,
2019 included a benefit of 6% or $1.7 million from sale of previously reserved
inventory. The gross margin excluding the benefit to the gross margin from the
sale of the previosly reserved inventoy increased by 6% year over year from
higher sales volume and an increase in ASP as other manufacturing costs remained
relatively flat.



Operating Expenses

Our operating expenses consist of research and development, sales and marketing,
and general and administrative expenses. Personnel costs are the most
significant component of our operating expenses and consist of salaries,
benefits, bonuses, stock-based compensation, and commissions. Our operating
expenses also include consulting costs, allocated costs of facilities,
information technology and depreciation. We expect our operating expenses to
fluctuate in absolute dollars and as a percentage of revenue over time.

Research and Development



Our research and development efforts are focused on the design and development
of next-generation silicon timing systems solutions. Our research and
development expense consists primarily of personnel costs, which include
stock-based compensation, pre-production engineering mask costs, software
license and intellectual property expenses, design tools and prototype-related
expenses, facility costs, supplies, professional and consulting fees, and
allocated overhead costs. We expense research and development costs as
incurred. We believe that continued investment in our products and services is
important for our future growth and acquisition of new customers and, as a
result, we expect our research and development expenses to continue to increase
in absolute dollars. However, we expect our research and development expense to
fluctuate as a percentage of revenue from period to period depending on the
timing of these expenses.



                                       17

--------------------------------------------------------------------------------

Sales, General and Administrative



Sales, general and administrative expense consists of personnel costs, including
stock-based compensation, professional and consulting fees, accounting and audit
fees, legal costs, field application engineering support, travel costs,
advertising expenses and allocated overhead costs. We expect sales, general and
administrative expense to continue to increase in absolute dollars as we
increase our personnel and grow our operations, although it may fluctuate as a
percentage of revenue from period to period depending on the timing of these
expenses.



                        Three Months Ended June 30,              Change              Six Months Ended June 30,              Change
                         2020                 2019             $         %           2020                2019             $          %
                                (in thousands except percentage)                            (in thousands except percentage)

Operating
Expenses:
Research and
development         $        7,398       $        6,249     $ 1,149       18 %   $      14,422       $      12,069     $ 2,353        19 %
Selling, general
and
administrative               7,856                5,106       2,750       54 %          15,664               9,297       6,367        68 %
Total operating
expenses            $       15,254       $       11,355     $ 3,899       34 %   $      30,086       $      21,366     $ 8,720        41 %



Research and development expense increased by $1.1 million, or 18%, for the three months ended June 30, 2020 compared to the same period in the prior year, primarily due to an increase in stock-based compensation expense of $1.1 million. This in turn was due to the timing of grants of employee equity awards upon the completion of our initial public offering in November 2019.



Selling, general and administrative expense increased by $2.8 million, or 54%,
for the three months ended June 30, 2020 compared to the same period in the
prior year, primarily due to higher stock-based compensation expense of $2.1
million, $0.5 million of higher personnel costs largely related to increased
headcount and expenses for services related to the requirements of being a
public company.



Research and development expense increased by $2.4 million, or 19%, for the six months ended June 30, 2020 compared to the same period in the prior year, primarily due to an increase in stock-based compensation expense of $2.0 million. This in turn was due to the timing of grants of employee equity awards upon the completion of our initial public offering in November 2019.



Selling, general and administrative expense increased by $6.4 million, or 68%,
for the six months ended June 30, 2020 compared to the same period in the prior
year, primarily due to higher stock-based compensation expense of $3.9 million,
higher personnel costs of $0.9 million largely related to increased headcount,
$0.5 million of additional legal expenses in connection with our patent
litigation matter and due to additional expenses for services related to the
requirements of being a public company.

Other Expense



Other income (expense) consists primarily of interest expense on our outstanding
debt, foreign exchange gains and losses, and asset dispositions. See Note 7 to
our consolidated financial statements under Item 8 for more information about
our debt.



                          Three Months Ended June 30,              Change               Six Months Ended June 30,              Change
                          2020                  2019            $          %            2020                 2019           $          %
                                  (in thousands except percentage)                             (in thousands except percentage)

Interest Expense      $         313         $         456     $ (143 )     (31 %)   $        616         $        894     $ (278 )      (31 %)
Other expense, net               20                    11          9        82 %             (48 )                 21        (69 )     (329 %)
Total other expense   $         333         $         467     $ (134 )     (29 %)   $        568         $        915     $ (347 )      (38 %)




Other expense decreased $0.1 million and $0.3 million for three and six months
ended June 30, 2020 compared to the same period in the prior year, primarily as
a result of lower interest rates on lower balances on our outstanding revolving
short-term debt during 2020 as compared to 2019.

Income Tax Benefit (Expense)



Income tax expense consists primarily of state income taxes and income taxes in
certain foreign jurisdictions in which we conduct business. We have a full
valuation allowance for deferred tax assets as the realization of the full
amount of our deferred tax asset is uncertain, including NOL, carryforwards, and
tax credits related primarily to research and development. We expect to maintain
this full valuation allowance until realization of the deferred tax assets
becomes more likely than not.



                                       18

--------------------------------------------------------------------------------


On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act ("CARES
Act") was signed into law in the U.S. to provide certain relief as a result of
the COVID-19 pandemic. In addition, governments around the world have enacted or
implemented various forms of tax relief measures in response to the economic
conditions in the wake of the COVID-19 pandemic. As of June 30, 2020, the
Company has determined that neither the CARES Act nor changes to income tax laws
or regulations in other jurisdictions had a significant impact on the Company's
effective tax rate.



                        Three Months Ended June 30,               Change               Six Months Ended June 30,              Change
                        2020                   2019            $         %            2020                   2019           $        %
                                (in thousands except percentage)                             (in thousands except percentage)

Income tax
benefit (expense)   $          1           $          (1 )   $   2     (200%)     $         (1 )         $         (1 )   $   -      0%



Liquidity and Capital Resources



Before our initial public offering in November 2019, we financed our operations
primarily through cash generated from product sales and proceeds from our credit
facilities, including proceeds from our loan agreement with MegaChips. As of
June 30, 2020 and December 31, 2019, we had cash and cash equivalents of
$102.5 million and $63.4 million, respectively. Our principal use of cash is to
fund our operations to support growth. In June 2020, we completed a follow-on
public offering of our shares, resulting in net proceeds to us of $45.8 million
after deducting underwriting discounts and commissions and deferred offering
costs. On July 24, 2020, the Company paid down all outstanding loans with MUFG
of $35.0 million and has initiated the closure of all credit facilities
available as of June 30, 2020. As of the reporting date, it is challenging to
assess the future impact of the COVID-19 pandemic on the Company. We believe
that one impact of the COVID-19 pandemic on the Company may be a decrease in the
Company's revenue. We are not currently aware of any other material short-term
adverse influences on the Company. However, at this point in time, we cannot
predict what other impacts the COVID-19 pandemic may have on the Company. We
believe that our existing cash and cash equivalents and funds available after
the paydown of our outstanding loans will be sufficient to meet our cash needs
for at least the next 12 months. Over the longer term, our future capital
requirements will depend on many factors, including our growth rate, the timing
and extent of our sales and marketing and research and development expenditures,
and the continuing market acceptance of our solutions. In the event that we need
to borrow funds or issue additional equity, we cannot provide any assurance that
any such additional financing will be available on terms acceptable to us, if at
all. If we are unable to raise additional capital when we need it, it would harm
our business, results of operations and financial condition.



                                                            Six Months Ended June 30,
                                                            2020                2019
                                                                 (in thousands)
Net cash provided by operating activities               $       5,655       $       5,176
Net cash used in investing activities                          (2,881 )            (1,342 )
Net cash provided by (used in) financing activities            36,294                 (62 )
Net increase in cash and cash equivalents               $      39,068       $       3,772




Operating Activities

In the six months ended June 30, 2020, net cash provided by operating activities
of $5.7 million was primarily due to a net loss of $10.7 million offset by
non-cash expenses of $10.5 million and an increase in operating assets and
liabilities of $5.8 million. Non-cash expenses were mainly related to
depreciation and amortization, impairment of internal-use software, stock-based
compensation expense, and non-cash operating lease costs. Operating assets and
liabilities increased primarily due to lower accounts receivables and related
party receivables due to timing of shipments and collections, lower prepaid
expenses and other current assets related to advance payments to suppliers for
inventory and higher accrued expenses and other liabilities due to timing of
payments partially offset by an increase in inventories as we managed our
inventory levels and lower lease liabilities due to timing of payments.

In the six months ended June 30, 2019, net cash provided by operating activities
of $5.2 million was primarily due to a net loss of $8.3 million offset by
non-cash expenses of $4.5 million and an increase in operating assets and
liabilities of $9.0 million. The increase in operating assets and liabilities
was primarily due to lower accounts receivable and related party receivables due
to timing of shipment and collections, a decrease in inventories due to lower
purchases primarily to manage our inventory levels, offset by lower accounts
payable due to timing of payments, lower accrued expenses and other liabilities
and lower lease liabilities. Non-cash items included depreciation and
amortization, and non-cash operating lease costs.



                                       19

--------------------------------------------------------------------------------

Investing Activities



Our investing activities consist primarily of capital expenditures for property
and equipment purchases. Our capital expenditures for property and equipment
have primarily been for general business purposes, including machinery and
equipment, leasehold improvements, acquired software, internally developed
software used in production and support of our products, computer equipment used
internally, and production masks to manufacture our products.

In six months ended June 30, 2020, cash used in investing activities was $2.9 million and consisted primarily of the purchase of production masks, internally developed software, and other property and equipment for general business purposes.

In six months ended June 30, 2019, cash used in investing activities was approximately $1.3 million and consisted primarily of the purchase of production masks, internally developed software, and other property and equipment for general business purposes.

Financing Activities

Cash provided by financing activities includes proceeds from borrowings under our credit facilities and proceeds from issuance of shares.



In six months ended June 30, 2020, net cash provided by financing activities was
$36.3 million, consisting of proceeds from issuance of shares of $45.8 million
net of underwriting commissions and discounts of $2.7 million and deferred
offering costs of $0.3 million and borrowings of $35.0 million offset by
repayments of $41.0 million under our short-term revolving line of credit and
$3.5 million payment of tax withholdings paid on behalf of employees for net
share settlement at the time of vesting.

In six months ended June 30, 2019 the Company paid $0.1 million in deferred offering costs.

Contractual Obligations and Commitments

Set forth below is information concerning our contractual commitments and obligations as of June 30, 2020:





                                                 Payments due by period
                                      Less than                                       More than
                         Total         1 year         1-3 years       3-5 years        5 years
                                                     (in thousands)

Debt obligations $ 35,000 $ 35,000 $ - $

- $ -


 Operating leases          9,980             646           3,103           3,021           3,210
 Purchase obligations        879             879               -               -               -
 Total                  $ 45,859     $    36,525     $     3,103     $     3,021     $     3,210




Obligations under contracts that we can cancel without a significant penalty are
not included in the table above. The aggregate amount of our obligations under
these contracts is approximately $11.4 million as of June 30, 2020.

We signed an operating lease agreement for our corporate headquarters in Santa
Clara, California that commenced on October 20, 2016 and will expire on
December 31, 2026. The agreement provides for an option to renew for an
additional five years and for rent payments through the term of the lease
payment. We also lease office space in Michigan, Malaysia, Japan, the
Netherlands, and Ukraine, and all under operating leases with various expiration
dates through December 2022.

We purchase components and wafers from a variety of suppliers and use several contract manufacturers to provide manufacturing services for our products. A significant portion of our reported purchase commitments arising from these agreements consists of firm, non-cancellable and unconditional purchase commitments once the production has started. In certain instances, these agreements allow us the option to cancel, reschedule, and adjust our requirements based on its business needs prior to firm orders being placed.

Off-Balance Sheet Arrangements



During the periods presented, we did not have any relationships with
unconsolidated entities or financial partnerships, such as entities often
referred to as structured finance or special purpose entities, which would have
been established for the purpose of facilitating off-balance sheet arrangements
or other contractually narrow or limited purposes.



                                       20

--------------------------------------------------------------------------------

Critical Accounting Policies and Estimates



The preparation of our financial statements and accompanying disclosures in
conformity with GAAP requires estimates and assumptions that affect the reported
amounts of assets, liabilities, revenues and expenses, and related disclosures
of contingent assets and liabilities in the consolidated financial statements
and the accompanying notes. The Securities and Exchange Commission, or SEC, has
defined a company's critical accounting policies as policies that are most
important to the portrayal of a company's financial condition and results of
operations, and which require a company to make its most difficult and
subjective judgments, often as a result of the need to make estimates of matters
that are inherently uncertain. Based on this definition, we have identified our
most critical accounting policies and estimates to be as follows: (1) revenue
recognition; (2) inventory; (3) stock-based compensation; (4) accounting for
income taxes and (5) segment reporting. Although we believe that our estimates,
assumptions, and judgments are reasonable, they are based upon information not
presently available. Actual results may differ significantly from these
estimates if the assumptions, judgments, and conditions upon which they are
based turn out to be inaccurate. Management believes that there have been no
significant changes to the items that we disclosed as our critical accounting
policies and estimates in Management's Discussion and Analysis of Financial
Condition and Results of Operations, in our Annual Report on Form 10-K for the
year ended December 31, 2019 filed with the SEC on March 3, 2020.

© Edgar Online, source Glimpses